Cargando…

Molecular subtypes and precision treatment of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Despite the progress made in precision treatment of cancer patients, targeted treatment is still at its early stage in TNBC, and chemotherapy remains the standard treatment. With the advances in next generation sequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shen, Zuo, Wen-Jia, Shao, Zhi-Ming, Jiang, Yi-Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210152/ https://www.ncbi.nlm.nih.gov/pubmed/32395543 http://dx.doi.org/10.21037/atm.2020.03.194

Ejemplares similares

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
por: Jiang, Yi-Zhou, et al.
Publicado: (2020)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
por: Liu, Yi-Rong, et al.
Publicado: (2016)

Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis
por: Li, Jia-Wei, et al.
Publicado: (2020)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
por: Ding, Jia-Han, et al.
Publicado: (2022)

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
por: Liu, Yin, et al.
Publicado: (2023)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
por: Lin, Cai-Jin, et al.
Publicado: (2023)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
por: Tong, Ling, et al.
Publicado: (2023)

A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
por: Tseng, Ling-Ming, et al.
Publicado: (2017)

CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer
por: Cheng, Tianyi, et al.
Publicado: (2022)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

The advance of adjuvant treatment for triple-negative breast cancer
por: Ge, Jingyu, et al.
Publicado: (2022)

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
por: Le Du, Fanny, et al.
Publicado: (2015)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
por: Su, Guan-Hua, et al.
Publicado: (2022)

Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes
por: Kim, Ja Young, et al.
Publicado: (2012)

Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy
por: Xu, Ming, et al.
Publicado: (2022)

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
por: Jiang, Lin, et al.
Publicado: (2022)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning
por: Bissanum, Rassanee, et al.
Publicado: (2021)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes
por: Jiang, Jinxia, et al.
Publicado: (2021)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
por: Zhou, Yi-Fan, et al.
Publicado: (2021)

Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer
por: Luo, Lixi, et al.
Publicado: (2022)

Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype
por: Shao, Fangyuan, et al.
Publicado: (2017)

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
por: Masuda, Hiroko, et al.
Publicado: (2017)

Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
por: Hessel, Harald, et al.
Publicado: (2018)

Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
por: Jézéquel, Pascal, et al.
Publicado: (2015)

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
por: Pareja, Fresia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d0qgfai6gpbp4uk8j4l1v5f6bo